Jonathan Oppenheim

Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.

Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK.

Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (Germany) GmbH is a company that invests in science to improve people's lives. The company is based in Munich, Germany. The company is focused on discovering, developing, and producing innovative medicines for individuals with serious diseases. The CEOs are Ashley Alexander Grist, Georg Pirmin Meyer, Yves Alexander Zinggeler. The company was founded in 2011.

Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom.